Tiril Østefjells1, Ingrid Melle2, Roger Hagen3, Kristin L Romm4, Nasrettin Sönmez5, Ole A Andreassen6, Jan Ivar Røssberg7. 1. NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, 0424, Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, 0424, Oslo, Norway; Department for Specialised Inpatient Treatment, Division of Mental Health and Addiction, Akershus University Hospital, 1478 Lørenskog, Norway. Electronic address: tiril.ostefjells@medisin.uio.no. 2. NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, 0424, Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, 0424, Oslo, Norway. Electronic address: ingrid.melle@medisin.uio.no. 3. Department of Psychology, Norwegian University of Science and Technology, 7491 Trondheim, Norway. Electronic address: roger.hagen@svt.ntnu.no. 4. Division of Mental Health and Addiction, Oslo University Hospital, 0424, Oslo, Norway. Electronic address: k.l.romm@medisin.uio.no. 5. Division of Mental Health and Addiction, Oslo University Hospital, 0424, Oslo, Norway. Electronic address: nasrettin.sonmez@diakonsyk.no. 6. NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, 0424, Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, 0424, Oslo, Norway. Electronic address: o.a.andreassen@medisin.uio.no. 7. NORMENT, KG Jebsen Centre for Psychosis Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, 0424, Oslo, Norway; Division of Mental Health and Addiction, Oslo University Hospital, 0424, Oslo, Norway. Electronic address: j.i.rossberg@medisin.uio.no.
Abstract
BACKGROUND: Previous studies have shown that individuals with schizophrenia exhibit higher levels of unhelpful metacognitive beliefs than healthy controls, but no studies have explored metacognitive beliefs in early psychosis. AIMS: We examined i) differences in levels of unhelpful metacognitive beliefs between psychosis spectrum disorders, and healthy controls, and ii) to what extent demographic and clinical characteristics predicted levels of metacognitive beliefs in the early treated phases of psychotic disorders. METHOD: Patients were included within two years of first treatment for a psychotic disorder (N=92). They were assessed on premorbid adjustment, psychotic symptoms, anxiety/depression, and self-reported metacognitive beliefs (MCQ-30). Ninety-seven controls also completed MCQ-30. Predictors of metacognitive beliefs were explored with multiple linear regression analyses. RESULTS: Patients scored significantly higher than controls on all metacognitive subscales except positive beliefs about worry. The regression model explained 14-38% of the variance on each metacognitive subscale. Current affective symptoms explained a significant amount of variance on all subscales, except positive beliefs about worry. Childhood (premorbid) social adjustment predicted a significant amount of the variance on all subscales, except cognitive confidence. Duration of untreated psychosis contributed significantly to more unhelpful beliefs about cognitive confidence. Negative symptoms predicted lower scores on cognitive self-consciousness. CONCLUSION: Affective symptoms and childhood social adjustment could be important predictors of unhelpful metacognitive beliefs in the early treated phases of psychosis, indicating potential psychopathological relationships that warrant further investigation for clinical relevance.
BACKGROUND: Previous studies have shown that individuals with schizophrenia exhibit higher levels of unhelpful metacognitive beliefs than healthy controls, but no studies have explored metacognitive beliefs in early psychosis. AIMS: We examined i) differences in levels of unhelpful metacognitive beliefs between psychosis spectrum disorders, and healthy controls, and ii) to what extent demographic and clinical characteristics predicted levels of metacognitive beliefs in the early treated phases of psychotic disorders. METHOD:Patients were included within two years of first treatment for a psychotic disorder (N=92). They were assessed on premorbid adjustment, psychotic symptoms, anxiety/depression, and self-reported metacognitive beliefs (MCQ-30). Ninety-seven controls also completed MCQ-30. Predictors of metacognitive beliefs were explored with multiple linear regression analyses. RESULTS:Patients scored significantly higher than controls on all metacognitive subscales except positive beliefs about worry. The regression model explained 14-38% of the variance on each metacognitive subscale. Current affective symptoms explained a significant amount of variance on all subscales, except positive beliefs about worry. Childhood (premorbid) social adjustment predicted a significant amount of the variance on all subscales, except cognitive confidence. Duration of untreated psychosis contributed significantly to more unhelpful beliefs about cognitive confidence. Negative symptoms predicted lower scores on cognitive self-consciousness. CONCLUSION: Affective symptoms and childhood social adjustment could be important predictors of unhelpful metacognitive beliefs in the early treated phases of psychosis, indicating potential psychopathological relationships that warrant further investigation for clinical relevance.
Authors: Mihwa Han; Kyunghee Lee; Mijung Kim; Youngjin Heo; Hyunseok Choi Journal: Int J Environ Res Public Health Date: 2021-06-25 Impact factor: 3.390